FDA's Advisory Committees to Meet on Bone, Reproductive, and Urologic Drugs and Drug Safety

Summary

The FDA's Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will convene for a meeting to discuss various topics related to bone, reproductive, and urologic drugs, as well as drug safety and risk management.